round 11 partner information session n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Round 11 Partner Information Session PowerPoint Presentation
Download Presentation
Round 11 Partner Information Session

Loading in 2 Seconds...

play fullscreen
1 / 73

Round 11 Partner Information Session - PowerPoint PPT Presentation


  • 108 Views
  • Uploaded on

Round 11 Partner Information Session. IFRC Global Fund Round 11 workshop 3 October 2011 Geneva, Switzerland. Objectives for the day. Provide factual and detail information on Round 11 application materials Put Round 11 in the wider context Explain how the TRP functions

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Round 11 Partner Information Session' - alima


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
round 11 partner information session

Round 11Partner Information Session

IFRC Global Fund Round 11 workshop

3 October 2011

Geneva, Switzerland

slide2

Objectives for the day

  • Provide factual and detail information on Round 11 application materials
  • Put Round 11 in the wider context
  • Explain how the TRP functions
  • Present new eligibility, counterpart financing and prioritization policy, new CCM requirements
  • Opportunity for Q & A with GF Secretariat teams
slide3

Agenda

  • Recent Board decisions and timelines
  • Overview TRP
  • New eligibility, counterpart financing & prioritization policy
  • New architecture and consolidated proposals
  • Applications material for R11
the board decided to delay the round 11 submission deadline and examine options
The Board decided to delay the Round 11 submission deadline and examine options

BD: GF/B24/DP4

Addressing Funding and Approval Process for Round 11, Second Wave of National Strategy Applications (NSAs) and Health Systems Strengthening Platform (HSFP)

The Board recognizes uncertainties in relation to the expected funding envelope for Round 11, the Second Wave of NSAs and HSFP applications and notes that it has been revised downward to a current estimate of not more than US$0.8 billion, which may not be available until the fourth quarter of 2013.

The Board and the Secretariat will examine options for modification of the application, renewal and approval processes for new and existing investments in light of these resource constraints, the recommendations of the High Level Panel and the Global Fund’s strategy and reform processes. The Board will communicate the results of those deliberations no later than 1 December 2011. These deliberations will also consider options for reallocation of existing commitments to prioritize high-impact interventions, which could increase resources available for new investments.

As a result of the expected delay in availability of resources, the Board extends the application deadline for Round 11, the Second Wave of NSAs and HSFP applications until at least 1 March 2012.

the website has been updated accordingly
The Website has been updated accordingly
  • “The Board made an important decision at its 24th Board Meeting on 26 September 2011 relating to Round 11 proposals, Second Wave of National Strategy Applications and funding requests through the Health Systems Funding Platform. Due to uncertainties in the amount of financing which is expected to be available to fund this Round, the Board has agreed to:
  • Delay the closing date for Round 11 proposals, Second Wave of National Strategy Applications and funding requests through the Health Systems Funding Platform from 15 December 2011 to at least 1 March 2012;
  • Examine options for modifications to the application, renewal and approval processes for new and existing investments; and
  • To make further decisions in relation to the options at its forthcoming 25th Board Meeting on 21-22 November 2011.
  • Applicants are therefore informed that the application, renewal and / or approval processes for new and existing grants are liable to change.
  • The Board made these decisions in recognition of a revised current estimate that not more than US$ 0.8 billion is expected to be available for approving Round 11 proposals Second Wave of National Strategy Applications and funding requests through the Health Systems Funding Platform, and the fact that these resources may not be available until the fourth quarter of 2013.
  • The Board has committed to communicating its decision on the modifications that may apply to the application, renewal and approval processes no later than 1st December 2011. However, until such time, the existing application forms, processes and guidance for Round 11 (including the Eligibility List (PDF - 645 KB)), the Second Wave of NSAs and the Health Systems Funding Platform remain valid and applicable (although they are subject to future changes). Further information will be provided following the Board decisions no later than 1 December 2011”
important questions and answers 1 2
Important questions and answers (1/2)
  • The Global Fund 2011 eligibility list remains valid until the Board makes a decision at its meeting in November 2011

Will the eligibility list be updated?

  • The implications for applicants will become clear after the Board meeting in November 2011
  • However, applicants should not make the assumption that they will become eligible and that the proposal no longer has to be consistent with the proposal concept

Will this affect applicants with proposal concepts (related to “funding history”)?

Will the current application forms remain the same?

  • The current application forms remain valid but are subject to future changes
  • But the Board is considering modifications to the application, renewal and approval processes this could affect the forms
important questions and answers 2 2
Important questions and answers (2/2)
  • The Board will examine options for Round 11, Second Wave of NSAs and HSFP proposals in light of resource constraints
  • Further guidance only available after 1 December 2011

What happens if demand exceeds the $0.8bn

  • Prospective applicants may wish to consider reallocation of other funds, including from existing grants, to meet critical gaps that need addressing earlier
  • Further guidance only available after 1 December 2011

What does the potentially “late availability” of funding mean for applicants?

slide8

Agenda

  • Recent Board decisions and timelines
  • Overview TRP
  • New eligibility, counterpart financing & prioritization policy
  • New architecture and consolidated proposals
  • Applications material for R11
proposals process overview

Signature &

First Disbursement

PR: Grant Negotiations

Proposals Process: Overview

Board: Call for Proposals

Applicant (CCM): Proposal Development

Secretariat: Screening

TRP: Technical Review

1 - Recommended

Board Approval

2 – Rec. Minor changes

Periodic Reviews

3 - Re-submission

CCM: TRP clarifications(as required)

4 - Rejected

proposals process pre technical review

Secretariat: Eligibility Screening

Proposals Process: Pre-Technical Review

NEW CCM Guidelines

  • 6 minimum eligibility requirements reviewed at proposal
  • submission
  • Ensure the input of a broad range of stakeholders, key population groups and most-at-risk populations
  • Have documented and transparent processes to:
    • Solicit and review submissions of proposals for possible integration into a consolidated national proposal
    • Nominate the Principal Recipient (s)
  • Conflict of Interest plan in place
technical review panel

TRP: Funding recommendations to the Board

Technical Review Panel
  • Who:
  • Group of independent and impartial experts appointed by the Board.
  • Diverse geographic and programmatic backgrounds
  • Consists of disease experts and cross-cutters
  • Review:
  • The TRP looks for proposals that equally demonstrate 27 review criteria, reflecting:
    • Soundness of approach
    • Feasibility
    • Potential for sustainability & impact
    • Value for Money

TRP Review Criteria

slide12

For its assessment the TRP looks at the proposal and additional information

Documents reviewed by the TRP

Proposal From: proposal documentation as submitted by the applicant (including attachments)

Secretariat documentation on existing Global Fund grants (Grant Performance Reports, Grant Score Cards and country reports by disease, and previous TRP Review Forms)

Epidemiological data provided by WHO and UNAIDS (country profiles, progress reports and epidemiological fact sheets)

Other relevant documents from other donors

trp review process
TRP review process

Small groups of 4 members:

2 disease experts + 2 cross-cutters

Plenary session of 43 members:

Recommendations discussed & finalized

If necessary, second review:

Additional TRP members asked to provide 2nd recommendation

Final plenary :

Last day for quality assurance + lessons learned

trp review form
TRP Review Form
  • Summary of TRP decision and rationale
  • Comprehensive and specific feedback: key strengths and weaknesses
  • If applicants do not understand the comments  Proposals Inbox, technical partners
trp what makes a good proposal 1 of 2
TRP: What makes a good proposal? (1 of 2)
  • Interventions based upon and responding directly to current, documented, epidemiological situation
  • Coherent strategy, based on national strategies
  • Robust gap analysis
  • Clear and realistic analysis of implementation and absorptive capacity constraints
  • Logical strategy to address capacity constraints
trp what makes a good proposal 2of 2
TRP: What makes a good proposal? (2of 2)
  • Appropriate implementation arrangements
  • A clear plan for how to monitor activities and evaluate the impact of interventions
  • Detailed budget and clear workplan
  • Planned outcomes included as indicators in the ‘Performance Framework’

For more information, TRP Reports Rounds 8-10

key weaknesses all diseases and hss
Key weaknesses – all diseases and HSS
  • Not evidence-based or are part of an inappropriate approach for the epidemiological context.
  • Lacks a coherent strategy.
  • Inconsistencies between objectives, SDAs, activities, budget and indicators.
  • insufficient detailed information to assess the feasibility.
  • Impact and/or outcome indicators are inappropriate or poorly defined (weak performance framework).
  • The budget is inaccurate or not sufficiently detailed.

Information Note, “Most Common Weaknesses Identified by TRP”

slide19

Agenda

  • Recent Board decisions and timelines
  • Overview TRP
  • New eligibility, counterpart financing & prioritization policy
  • New architecture and consolidated proposals
  • Applications material for R11
in 2011 the board approved a new eligibility counterpart financing prioritization policy
In 2011 the Board approved a new eligibility,counterpart financing & prioritization policy
  • Determines whether an applicant is eligible to apply; for which component and under which conditions
    • Two pools of funding: “general” and “targeted” (like the MARPs channel in Round 10)
    • Addition of a “history of recent funding” provision to the eligibility criteria;
  • Refers to the minimum level of the government’s contribution to the national disease programme
    • Requirement that all countries – including low income countries – make a minimum contribution to funding the national disease programme
  • Comes into play when there is not enough money to cover all of the proposals recommended for funding

Eligibility

Counterpart Financing

Prio-ritization

eligibility two pools of funding
Eligibility: Two pools of funding

Two pools of funding

  • GENERAL:
  • 90% available funding allocated
  • Applicants are free to choose between pools, except for upper-middle income countries with high disease burdens
  • Applicants cannot apply to both pools for the same disease component
  • TARGETED:
  • 10% available funding allocated
  • No cross-cutting HSS
  • Budget ceilings

Each pool covers all three diseases

eligibility focus of proposals is a key difference between two pools
Eligibility: Focus of proposals is a key difference between two pools
  • All applications must focus 100% on key populations and/or “highest impact interventions” regardless of income level.
  • GENERAL
  • Do not have to meet any focus criteria

LICs

L-LMICs & U-LMICs

  • LMIs must focus at least 50% on “underserved and most-at-risk populations” and/or “highest impact interventions.”

UMICs

  • UMIs must focus 100% on “underserved and most-at risk populations” and/or “highest impact interventions”.

Definition on next slide

  • TARGETED
  • The TRP (not the Secretariat) will determine whether applicants meet the proposal focus requirements during its proposal review.
eligibility definition of focus
Eligibility: Definition of focus

Underserved and most-at-risk population

  • Defined within a defined and recognized epidemiological context
  • Have significantly higher levels of risk, mortality and/or morbidity; AND
  • Have significantly lower access to, or uptake of, relevant services is than the rest of the population

Highest impact interventions

  • Defined within a defined and recognized epidemiological context
  • Address emerging threats to disease control, lift barriers to the broader disease response and/or create conditions for improve service delivery
  • And/or enable the roll-out of new technologies that represent best practice; AND
  • Are not adequately funded
eligibility additional requirements history of recent funding
Eligibility: additional requirements – history of recent funding

Exception criteria

  • Applicants that have received funding for the same disease or cross-cutting HSS component which has been implemented for less than 12 months cannot submit a proposal for the same component
  • 12-month period calculated from the implementation start date to the closing date for submission of proposals

Rule

  • The proposal corresponds to either one of the exemption situations
    • A proposal has a different geographical coverage than previous proposal
    • A proposal calls for the roll-out of new technical guidance requiring significant investment
  • The need cannot be addressed through reprogramming of existing funds
  • There is adequate absorptive capacity and ability to roll-out the proposed new intervention

1

2

3

  • Applicants ineligible under this rule were able to apply by July 22nd for an exception
slide25

Counterpart Financing: Objectives

  • Improved additionality and sustainability
  • Shared responsibility that applies to all countries
  • Improved measurement and accountability over time
counterpart financing main criteria
Counterpart Financing: Main Criteria

1

Minimum threshold:

  • Governments of all applicant countries are required to make a minimum contribution to the country’s national disease program
  • Minimum contributions*:
    • Low income countries: 5%
    • Lower LMICs: 20%
    • Upper LMICs: 40%
    • Upper-middle income countries: 60%

Increasing contributions: Demonstrate that government contribution to the national disease program and to overall health spending is increasing each year

Improving expenditure data: Required to report information on financing for the national disease programs on an annual basis, and to show the source of the data in their reports.

If non-compliant applicant can submit justification and an action plan

2

3

  • These criteria apply whether the proposal is recommending gvt. or non-government Principal Recipients.
  • All applicants have to meet the counterpart financing criteria, independent of income level (except for regional and non-CCM applicants).
slide27

How to calculate the minimum threshold?

1

Government Contribution

Government contribution

  • Annual average govt funding earmarked for disease for past two years expenditure (e.g. 2009 and 2010) and the current year (e.g. budget 2011)
    • Govt revenues
    • Govt borrowings from external or private creditors (e.g. World Bank loans)
    • Debt relief proceeds

GF Financing

  • Annual average of funding requested and other existing Global Fund grants for first three years of implementation
counterpart financing disclaimer
Counterpart Financing: Disclaimer!

2

3

  • It is not perfect but a good start!
  • Steps taken to address the issues
  • Grant funding can be used by countries to conduct disease expenditure assessments (NHAs, NASAs etc)
  • Board approved additional funding for GF to collaborate with partners on improving quality of their databases – GMP, STOP TB, UNAIDS, and WHO NHA
prioritization will take place if there aren t sufficient funds
Prioritization will take place if there aren’t sufficient funds
  • Only to be used when there are insufficient funds for all TRP-recommended proposals at the time of Board approval
  • Different prioritization model for each of the two funding pools
  • GENERAL
  • TARGETED
  • Surplus funds (if any) will be transferred from the Targeted Funding Pool to the General Funding Pool (or vice versa)
prioritization general funding pool
Prioritization: General Funding Pool
  • GENERAL
  • Builds on the Round 10 model
  • Gross national income (GNI) per capita will be used as the “tie breaker” for countries with same score
  • Scores for multicountry proposals will reflect the average for the individual countries included
  • The total allocation given to upper-middle income countries will not exceed 10% of a funding window
prioritization targeted funding pool
Prioritization: Targeted Funding Pool
  • TARGETED

2-step process

Review

Score

The TRP will prioritize proposals being recommended for funding in the Targeted Pool

  • Review of proposals
  • Category 1, 2 or 2B
  • Score for each proposal
  • Based on a methodology developed and agreed on by the TRP
  • Income level will not be factored in
slide33

Agenda

  • Recent Board decisions and timelines
  • Overview TRP
  • New eligibility, counterpart financing & prioritization policy
  • New architecture and consolidated proposals
  • Applications material for R11
slide34

New grant architecture: context & overview

  • Context
  • The old grant architecture was designed at the GF’s inception and has been added to over time
  • This grant architecture has supported the achievement of powerful results
  • And yet, the grant architecture proved overly complex and not scalable

New grant architecture (as approved by GF Board in November 2009):

Single Stream of Funding per PR in each disease

Consolidated disease proposal

Periodic Reviews

  • Objectives of new grant architecture:
  • Streamline grant management
  • Enable improved alignment to country plans, programsand cycles
  • Facilitate a shift from projects to a program-based approach
gf funding kenya tb program

1. Single Steam of Funding

GF Funding: Kenya TB Program

Under the “old” grant architecture…

Grant Closure

Round 5

Phase 2

Progress Update / Disbursement

Grant Closure

Phase 2

MoF

Round 6

Phase 2 Review

Grant Closure

Phase 1

Phase 2

Round 9

Grant Closure

Phase 1

Phase 2

AMR

Round 9

2010

2011

2012

2013

2014

2015

2016

2017

  • Key Features:
  • Different grants for each PR, with different budgets, workplans, M&E indicators, etc. with at least 2 PU/DRs every six months.
  • Grant close-out requirements for activities still ongoing with same PR
  • Several different “project-based” Phase 2 reviews
  • Misalignment with national reporting and fiscal cycles
  • Multiple grants = multiple Audit Reports and Enhancing Financial Reporting
1 single stream of funding

1. Single Steam of Funding

1. Single Stream of Funding

Single Stream of Funding per Principal Recipient (PR), per disease/HSS program is a foundational feature of the new grant architecture

  • Maintains core Global Fund principals
    • Dual track financing
    • Performance based funding
    • Progress updates and disbursement requests (PU/DR), EFR, OSDV…
    • Periodic performance reviews
  • With additional aspects for new single streams of funding
    • Single funding agreement per PR, per disease/HSS program
    • Fixed regular Implementation Periods of up to 3 years
    • Alignment of Implementation Periods with country cycles
    • Alignment of all PRs in a disease area so that periodic disease program reviews are possible
gf funding kenya tb program1

1. Single Steam of Funding

GF Funding: Kenya TB Program

Progress Update / Disbursement

Under the “new” grant architecture…

Implementation Period start / end

Periodic Review

1st implementation period

2nd Implementation period

MoF SSF

1st implementation period

2nd Implementation period

AMR SSF

2011

2012

2013

2014

2015

2016

2017

2018

  • Key features:
  • Transition to SSFs through R9 grant signings
  • 1 Single Stream Funding per PR, with one budget, workplan, performance framework
  • Reporting significantly reduced and more program-based
  • More holistic periodic review across PRs, aligned to national programmatic reporting cycle
  • Financial commitments aligned to national fiscal cycle
slide38

1. Single Steam of Funding

Entry points for transitioning to SSFs

2 consolidated proposals

2. Consolidated Proposals

2. Consolidated Proposals

Disease/HSS Program

Expected benefits include:

  • Encourages more holistic, program-based in-country resource planning
  • Facilitates rethinking of the program and implementation arrangements
  • Enables CCMs to coordinate the development of proposals based on the larger programmatic picture, and to provide better oversight during implementation
  • Provides TRP with holistic picture of the program for decision making

2012

2015

2018

PR1

PR2

PR3

  • Consolidated Proposal includes:
  • Continuation of existing & new activities for PR1 & PR2
  • Introduction of new PR3

Start of activities from consolidated proposal

Means to create and maintain SSFs

consolidated proposal vs grant consolidation

2. Consolidated Proposals

Consolidated Proposal vs. Grant Consolidation
  • Consolidated Proposals are not the same as Grant Consolidation
  • Consolidated Proposal:
    • A completeprogrammatic picture of the funding requested from the Global Fund for a disease/HSS program for the duration of the proposal term; and
    • A request for additional money above what is expected from existing grants/SSFs (incremental amount) in order to expand program coverage and scale-up activities.
  • Grant Consolidation (to transition to SSF):
    • Happens at the level of the individual Principal Recipient (outside of the proposals process); and
    • Involves merging two or more existing grants for the same Principal Recipient and disease/HSS program into a single grant agreement.
what happens if the consolidated proposal is approved

2. Consolidated Proposals

What happens if the consolidated proposal is approved?
  • Following approval of a Round 11 proposal:
  • if the country is receiving funding for the first time for a given disease/HSS program: a single stream of funding agreement will be signed for each Principal Recipient; or
  • if the country has nottransitioned to the new grant architecture for a given disease/HSS program: a single stream of funding agreement will be signed for each Principal Recipient, replacing any existing grant agreement(s); or
  • if the country hastransitioned to the new grant architecture for a given disease/HSS program: the existing single stream of funding agreement will be amended for the existing Principal Recipient. A newly nominated Principal Recipient in this situation would sign a new single stream of funding agreement.
  • *If the proposal is not approved, existing activities and funding are not affected
slide43

Agenda

  • Recent Board decisions and timelines
  • Overview TRP
  • New eligibility, counterpart financing & prioritization policy
  • New architecture and consolidated proposals
  • Applications material for R11
round 11 application materials have been improved
Round 11 application materials have been improved

Revised forms

  • Restructured and simplified Proposal Form and more practical guidelines

New tools

  • New/improved tools to help applicants with consolidated disease proposals
    • New Applicant Disease Profile (ADP) will provide applicants with existing Global Fund grants an overview of their current financial and programmatic portfolio
    • Logframeadded to interventions section to help applicants prepare a consolidated summary of their programmatic request

New measures

  • New measures to help smooth the transition to grant signing
    • Clear delineation of responsibilities between PRs in logframe, performance framework, budget and work plan
    • Introduction of “PR endorsement” to ensure PRs aware of nomination at time of proposal submission
overview of important documents for round 11
Overview of important documents for Round 11

Proposal Form

Guidelines

Proposal inbox

proposals@

theglobalfund.org

Information notes

Online FAQs

And many other online resources from partners

applicant disease profiles are a new tool to support applicants
Applicant Disease Profiles are a new tool to support applicants
  • New tool in Round 11
  • Provides applicants with
    • Application history (with CCM info)
    • Existing grants information (financial and programmatic)
  • Targeted to support consolidated disease proposals
    • Complimented by epidemiological partner reports
overview of all required proposal forms and what to fill out for what
Overview of all required proposal forms and what to fill out for what

Applicable to

Form

  • Section 1-2
  • Section 3-8
  • Applicant
  • Component
  • Attachment A Performance Framework
  • Attachment B Preliminary list of Pharmaceutical and Health Products
  • Attachment C Membership details of coordinating mechanisms
  • Attachment D Logframe
  • Attachment E Budget, workplan & related tables
  • Attachment F Budget related tables
  • Other Eligibility supporting documentation (e.g. meeting minutes)
  • Component
  • Component
  • Applicant
  • Component
  • Component
  • Applicant

Attach-ments

ATM

Either or

Form

  • Part A- Proposal Summary and Applicant Information
  • Part B- Applicant Eligibility
  • Part C- Proposal Details
  • Component
  • Component
  • Component

Only parts of it mandatory if applied for other ATM component

  • Attachment 2- HSS Logframe
  • Attachment 4- Performance Framework
  • Attachment 5- Financial gap analysis, detailed work plan and detailed budget

HSS

Attach-ments

  • Component
  • Component
  • Component
disease component section 1 applicant info funding summary
Disease componentSection 1: Applicant Info & Funding Summary
  • Country/economy eligibility information
  • Funding summary and choice of funding pool
  • Contact details
disease component section 2 ccm eligibility
Disease componentSection 2: CCM Eligibility
  • Makes use of proposal wizard to give applicants only the specific sections they need (CCM, non-CCM, etc.)
  • Link between questions and six minimum CCM eligibility requirements emphasized
  • Proposal development and PR selection processes (dual-track financing) highlighted
  • Certain questions not relevant to CCM eligibility screening removed (e.g., Knowledge in Cross-Cutting Issues)
disease component section 3 country context
Disease componentSection 3: Country Context
  • New section in Round 11
  • Consolidates all contextual background information, including:
    • National Program
    • Major Constraints and Gaps
    • Efforts to Resolve Weaknesses and Gaps
    • Epidemiological Profile (updated tables)
    • Round 11 Priority Interventions
  • Draws on Applicant Disease Profile and related partner country profiles
disease component section 4 proposal summary
Disease componentSection 4: Proposal Summary
  • New section in Round 11
  • Duration of proposal and Executive summary
  • Consolidated Interventions
    • New logframe
  • Links to non GF resources
  • Addressing weaknesses from a previous category 3
  • TB/HIV collaborative activities (if applicable)
  • Emphasis on mainstreaming of “policy” questions
disease component section 5 monitoring and evaluation
Disease componentSection 5: Monitoring and Evaluation
  • No major changes to the GF Performance Framework
  • Impact and outcome measurement
    • Including links to Periodic Review
  • Links with national M&E system
  • Strengthening M&E systems
disease component section 6 pharmaceutical other health products 1 2
Disease componentSection 6: Pharmaceutical & other Health Products (1/2)
  • Pharmaceutical and health products for initial three years of implementation
  • No major changes to the GF List of Pharma and Health Products (Attachment B)
  • MDR TB (HIV and TB proposals only)
disease component section 7 funding request
Disease componentSection 7: Funding Request
  • Revised financial gap analysis and counterpart financing table and narrative questions – Reflects new CF requirements
  • New question on compliance with focus of proposal requirements
  • Changes to the GF budget and work plan template
  • Mandatory Excel summary (by SDA, Cost category and PR) budget tables and incremental request calculation
disease component section 8 management strategies
Disease componentSection 8: Management Strategies
  • New section in Round 11
  • PRs identified and aware of nomination (new)
  • Emphasis on PR/SR coordination
key steps for consolidated proposal development
Key steps for consolidated proposal development
  • List and link existing and new activities in the proposal logframe
  • List discontinued activities in a separate table
  • Create the narrative following the logframe, describing the goals, objectives, service delivery areas (SDAs), and activities of the consolidated proposal
  • Complete the Performance framework template showing an overall view for all PRs nominated in the R11 proposal
  • Develop the consolidated budget and workplan
  • Calculate the incremental funding request

1

2

3

4

5

6

in round 11 hss is a separate component
In Round 11 HSS is a separate component
  • Available to all Global Fund eligible countries in Round 11
  • Form replaces what was previously known as section 4B/5B
  • Jointly developed with GAVI
    • Form can be used for GAVI and GF applications
    • When used for both agencies, form only needs to be filled in once (but the applicant needs to clearly delineate the funding request to the two agencies and how this is linked to specific objectives)

Common HSS Proposal Form

  • All HSS proposals still need to demonstrate linkages with improved outcomes in HIV/AIDS, TB and malaria
  • The proposed HSS activities will have to improve the health system’s performance in terms of outcomes for two or more of the three diseases
however applicants may include hss within the disease application
However, applicants may include HSS within the disease application

Include HSS in disease

HSS interventions are integrated into the disease application(s)

Considerations-

  • Do the proposed HSS activities result in improved outcomes in reducing the burden of two or more of the three diseases?
  • Will the ensuing grant be more effectively managed, monitored and reported on as a separate HSS grant?

HSS separate

HHS interventions are applied for through the new HSS Common Proposal Form

slide59

Eligibility and Counterpart Financing for ccHSS

  • No disease burden criteria for ccHSS for LIC and LMIC
  • UMI countries with severe or extreme disease burden for any disease eligible, but not if disease burden is only high

Eligibility – disease burden

  • All ccHSS proposals must be submitted to the General Pool
  • UMI countries eligible only for the Targeted Funding Pool cannot submit a ccHSS proposal

Eligibility - Pool

  • Minimum Counterpart Financing threshold for CC-HSS proposals is set at same levels as for disease proposals
  • Counterpart Financing in the context of CC-HSS proposals:
    • Government contribution: Total of government’s contribution to all national disease programs (HIV and AIDS, tuberculosis and/or malaria as applicable) which either have
      • Existing Global Fund support or
      • a funding request under consideration
    • Global Fund financing: The total of existing and requested/approved funding for the applicable diseases and CC-HSS

Counterpart Financing

slide60

Focus of proposals for ccHSS

Definition of focus

LICs

  • No restriction on scope

ccHSS interventions that address the needs of underserved populations’ defined as Health systems and community systems strengthening interventions that;

Improve equitable coverage and uptake addressing any/all

• Availability of services

• Access to services

• Utilization of services

• Quality of services

AND

Are not funded adequately

L-LMICs & U-LMICs

  • 50% of proposal focused (applicants must demonstrate at least 50 % of proposal‘s budget addresses needs of underserved populations)

UMICs

  • 100% of proposal focused (applicants must demonstrate 100% of proposal‘s budget addresses needs of underserved populations)

Compliance with all these criteria will be determined at the time of the TRP review.

common hss proposal form part a proposal summary applicant information
Common HSS Proposal FormPart A – Proposal Summary & Applicant information
  • Applicant name/type
  • Country
  • WHO region
  • Proposal title
  • Proposed start date and duration of support requested
  • Amount requested
  • Executive summary
common hss proposal form part b applicant eligibility 1 2
Common HSS Proposal FormPart B – Applicant eligibility (1/2)
  • Income level
  • Diseases benefiting from the HSS proposal
  • Focus of Proposals
  • ‘Narrative’ information related to Counterpart financing
  • CCM eligibility requirements
common hss proposal form part b applicant eligibility 2 2
Common HSS Proposal FormPart B – Applicant eligibility (2/2)

Scenarios

When does an applicant have to fill out Part B of the Common HSS proposal form?

Disease component and HSS

Applicant applies for disease component and Common HSS proposal form

  • Section 1-2 disease component
  • HSS Part B - partially

Excluding the CCM eligibility bit

HSS only

Applicant applies for common HSS proposal form only (no disease component)

  • HSS Part B - fully
slide64

Common HSS Proposal FormPart C – Section 1: Proposal Development Process

  • Summary of proposal development process
  • Summary of decision-making process
slide65

Common HSS Proposal FormPart C – Section 2: National Health System Context

  • National Health Sector
  • National Health Strategy or Plan (costed if available)
  • Health Systems Strengthening Policies or Strategies
  • Key Health Systems Constraints and Barriers
  • Current HSS Efforts
common hss proposal form part c section 3 hss objectives
Common HSS Proposal FormPart C – Section 3: HSS Objectives
  • HSS objectives prioritized in the proposal
  • Proposed objectives and key activities and their contribution to national goals
  • Evidence base and/or lessons learned
  • Main beneficiaries
common hss proposal form part c section 4 performance monitoring evaluation
Common HSS Proposal FormPart C – Section 4: Performance Monitoring & Evaluation
  • National M&E Plan and Performance Framework
  • M&E arrangements
  • Strengthening M&E systems
common hss proposal form part c section 5 gap analysis detailed work plan and budget
Common HSS Proposal FormPart C – Section 5: Gap analysis, detailed work plan and budget
  • Financial Gap Analysis
  • Detailed work plan and budget
  • Supporting information to explain and justify proposed budget
slide69
Common HSS Proposal FormPart C – Section 6: Implementation arrangements and capacities, and program oversight
  • Lead Implementers
  • Coordination between and among implementers
  • Non-implementation of dual track financing
  • Sub-implementers
  • Strengthening implementation capacity
  • Financial management
  • Governance and oversight arrangements
common hss proposal form part c section 7 risks and unintended consequences
Common HSS Proposal FormPart C – Section 7: Risks and unintended consequences
  • Major Risks
  • Unintended consequences
the round 11 microsite contains all relevant documents
The Round 11 microsite contains all relevant documents
  • Application Process Explained
  • Major changes
  • Key dates and timelines
  • FAQs
  • Information notes
  • Other guidance
  • Application materials
a trp microsite in the about us section contains all details related to the trp
A TRP microsite in the “about us” section contains all details related to the TRP

www.theglobalfund.org

  • Separate Microsite in the TRP
  • Detailed information on
    • Members
    • Recruitment Process
    • Clarification Process
    • Options for appeal
    • TRP reports
    • Appeal Panel Reports
    • TRP Lessons Learned